Published in Gan To Kagaku Ryoho on October 01, 1987
Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer (1996) 1.24
Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. Br J Cancer (1997) 0.94
Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose. Clin Exp Metastasis (1997) 0.77
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer (1998) 5.40
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A (1982) 2.39
Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol (1998) 2.27
Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med (1994) 2.27
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res (1998) 2.22
X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res (1999) 1.81
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol (2001) 1.63
Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res (1998) 1.61
Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410. Antimicrob Agents Chemother (1982) 1.54
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res (1990) 1.40
Detection of bcr/abl mRNA in stained bone marrow smears. Leukemia (1994) 1.40
Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol (1993) 1.39
Antipicornavirus flavone Ro 09-0179. Antimicrob Agents Chemother (1982) 1.39
Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation. Virology (1984) 1.28
Comparative studies on the mechanism of action of lincomycin, streptomycin, and erythromycin. Biochem Biophys Res Commun (1969) 1.27
Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine. Gan (1980) 1.25
Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood (2001) 1.20
Parvovirus B19-associated haemophagocytic syndrome with lymphadenopathy resembling histiocytic necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol (1997) 1.19
Platelet-derived growth factor stimulates the phosphorylation of ribosomal protein S6. FEBS Lett (1983) 1.18
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer. Br J Cancer (2012) 1.17
Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol (2000) 1.15
Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides. Antiviral Res (1990) 1.14
An SV40-induced initiation factor for protein synthesis concerned with the regulation of permissiveness. Nature (1974) 1.10
The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine. Bioorg Med Chem (2000) 1.10
High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leuk Res (1992) 1.10
Characterization of the Asian myopathy patients with VCP mutations. Eur J Neurol (2011) 1.08
Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull (1996) 1.08
Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int J Cancer (1995) 1.06
Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer (1995) 1.06
Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull (Tokyo) (1983) 1.05
Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun (1982) 1.04
Expression of beta3-adrenoceptors in rat detrusor smooth muscle. J Urol (1998) 1.03
Transforming growth factor beta-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. Infect Immun (1999) 1.03
Sensitivity of G-protein involved in endothelin-1-induced Ca2+ influx to pertussis toxin in porcine endothelial cells in situ. Br J Pharmacol (1994) 1.03
Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor. Biochem Biophys Res Commun (2000) 1.02
Protective activity of thymosin against opportunistic infections in animal models. Cancer Immunol Immunother (1983) 1.01
Mucosa-associated lymphoid tissue type lymphoma of the gallbladder associated with acute myeloid leukemia. Intern Med (1999) 1.01
Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor. Biochem Biophys Res Commun (1994) 1.01
Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis. (II). Its antiplatelet activities. Thromb Res (1993) 1.01
Effects of isoprenaline on cytosolic calcium concentrations and on tension in the porcine coronary artery. J Physiol (1993) 1.00
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models. Int J Cancer (1999) 0.99
Mechanisms of galanin-induced contraction in the rat myometrium. Br J Pharmacol (1998) 0.99
Surgical treatment of congenital dilatation of the bile duct with special reference to late complications after total excisional operation. J Pediatr Surg (1990) 0.99
Intraluminal tumor of the common bile duct as a metastasis of renal cell carcinoma. Intern Med (1996) 0.98
Infection of immunodeficient mice with a mouse-adapted substrain of the gray strain of Babesia microti. J Parasitol (1993) 0.98
Hemolytic activity of a cyclic peptide Ro09-0198 isolated from Streptoverticillium. Biochim Biophys Acta (1988) 0.98
Release of transfer ribonucleic acid from ribosomes. A G factor and guanosine triphosphate-dependent reaction. J Biol Chem (1970) 0.98
Role of GTP-protein and endothelium in contraction induced by ethanol in pig coronary artery. J Physiol (1993) 0.96
Histamine activates H1-receptors to induce cytosolic free calcium transients in cultured vascular smooth muscle cells from rat aorta. Biochem Biophys Res Commun (1986) 0.95
Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery. Br J Pharmacol (2000) 0.95
Giant magneto-elastic coupling in multiferroic hexagonal manganites. Nature (2008) 0.95
Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig. Br J Pharmacol (1995) 0.95
Mechanism of endothelium-dependent relaxation induced by thrombin in the pig coronary artery. Eur J Pharmacol (1998) 0.95
Enhanced contractile response to thrombin in the pregnant rat myometrium. Br J Pharmacol (2000) 0.95
Cloning and expression of subtilisin amylosacchariticus gene. J Biochem (1988) 0.94
A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia. Gastroenterol Jpn (1992) 0.94
Effects of lidocaine on intracellular Ca2+ and tension in airway smooth muscle. Anesthesiology (1993) 0.93
Identification, characterization, and functional analysis of heart-specific myosin light chain phosphatase small subunit. J Biol Chem (2000) 0.93
Characterization of genomic PIG-A gene: a gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood (1994) 0.93
Interaction of a cyclic peptide, Ro09-0198, with phosphatidylethanolamine in liposomal membranes. Biochim Biophys Acta (1988) 0.93
A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. Pharm Res (2001) 0.93
Evaluation of surgical resection for small hepatocellular carcinomas. Am J Surg (1996) 0.92
NH2-terminal fragments of the 130 kDa subunit of myosin phosphatase increase the Ca2+ sensitivity of porcine renal artery. J Physiol (1999) 0.92
Biological characterization of cyclothialidine, a new DNA gyrase inhibitor. Antimicrob Agents Chemother (1993) 0.92
Transient myosin phosphorylation at constant Ca2+ during agonist activation of permeabilized arteries. Am J Physiol (1992) 0.92
Ecchordosis physaliphora and its variants: proposed new classification based on high-resolution fast MR imaging employing steady-state acquisition. Eur Radiol (2013) 0.92
Endothelin induces the Ca(2+)-transient in endothelial cells in situ. Biochem Biophys Res Commun (1991) 0.91
Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol (1993) 0.91
Stimulation of protein phosphorylation in Swiss mouse 3T3 cells by human platelet derived growth factor. Biochem Biophys Res Commun (1981) 0.91
Stimulus-specific alteration of the relationship between cytosolic Ca(2+) transients and nitric oxide production in endothelial cells ex vivo. Br J Pharmacol (2000) 0.90
Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa. Biochem J (1994) 0.90
Interaction of tRNA with ribosomes--binding and release of tRNA. Cold Spring Harb Symp Quant Biol (1969) 0.90
Transcriptional up-regulation of p27(Kip1) during contact-induced growth arrest in vascular endothelial cells. Exp Cell Res (2001) 0.90
Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.89
Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. Clin Cancer Res (1995) 0.89
Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res (1995) 0.89
Quin2 microfluorometry and effects of verapamil and diltiazem on calcium release from rat aorta smooth muscle cells in primary culture. Circ Res (1988) 0.89
Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers. J Antimicrob Chemother (1987) 0.89
Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime. Antimicrob Agents Chemother (1985) 0.89
Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation. Br J Pharmacol (1996) 0.89
Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi. Int Immunol (1999) 0.89
Endothelin-1 inhibits and enhances contraction of porcine coronary arterial strips with an intact endothelium. Biochem Biophys Res Commun (1992) 0.89
Japanese Biliary Atresia Registry, 1989 to 1994. Tohoku J Exp Med (1997) 0.89
Outcome study of bilateral lateral rectus recession for intermittent exotropia in children. Ophthalmic Surg Lasers (1999) 0.89
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood (1998) 0.88
Thapsigargin-induced endothelium-dependent triphasic regulation of vascular tone in the porcine renal artery. Br J Pharmacol (1999) 0.88
Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. Br J Cancer (2007) 0.87
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta. Eur J Haematol (2001) 0.87
Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase. J Biol Chem (1994) 0.87
The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol (2000) 0.87
Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I). Its GPIIb/IIIa blockage on solid phase binding assay. Thromb Res (1993) 0.87
Outcome study of bilateral lateral rectus recession for intermittent exotropia in children. Trans Am Ophthalmol Soc (1997) 0.86
Vasorelaxation and inhibition of the voltage-operated Ca2+ channels by FK506 in the porcine coronary artery. Br J Pharmacol (1999) 0.86
Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta. Circ Res (1987) 0.86
Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine). Biol Pharm Bull (1998) 0.86
Proximal subtotal gastrectomy for the treatment of carcinoma of the upper third of the stomach: its indications based on lymph node metastasis and perigastric lymphatic flow. Surg Today (1995) 0.86
Effect of tube voltage on image quality in 64-section multidetector 3D CT angiography: Evaluation with a vascular phantom with superimposed bone skull structures. AJNR Am J Neuroradiol (2009) 0.86
Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets. Infect Immun (1984) 0.86